Skip to main content
GH
NASDAQ Life Sciences

Guardant Health Raises 2026 Revenue Outlook After 44% Q2 Surge

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$162.37
Mkt Cap
$21.53B
52W Low
$40.355
52W High
$176.58
52W Position info
302% above low
Off High info
8.0% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

GH has more than doubled off its 52-week low of $40.355.

Summary

Guardant Health lifted its full-year revenue guidance to $1.34B-$1.36B, above the $1.31B consensus, after Q2 revenue jumped 44% to $335M, beating estimates by $20.8M. The raise follows the Q2 8-K filed yesterday and reflects accelerating test volumes—oncology revenue up 38% and screening revenue surging 257%. The stock added 6.1% Friday, extending its year-to-date gain to nearly 60%. Despite a wider GAAP loss from commercial investments, the top-line momentum and raised outlook signal strong demand for its liquid biopsy and screening tests. Watch for the 424B prospectus supplement tied to the July 30 S-3ASR shelf, which could indicate capital-raising plans.

At the time of this announcement, GH was trading at $162.37 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $21.5B. The 52-week trading range was $40.36 to $176.58. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

GH - Latest Insights

GH
Nov 12, 2026, 1:09 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $155.00
Real-time Price: $151.70 info
Change: -$3.30 (-2%) info
Market Cap: $20.523B info
GH
Nov 11, 2026, 4:17 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $154.78
Real-time Price: $151.70 info
Change: -$3.08 (-2%) info
Market Cap: $20.523B info
GH
Nov 05, 2026, 5:13 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $130.02
Real-time Price: $151.70 info
Change: +$21.68 (+17%) info
Market Cap: $20.523B info
GH
Nov 05, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $159.34
Real-time Price: $151.70 info
Change: -$7.64 (-5%) info
Market Cap: $20.523B info
GH
Oct 08, 2026, 4:12 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $165.56
Real-time Price: $151.70 info
Change: -$13.86 (-8%) info
Market Cap: $20.523B info